Where Spike (LC-MS/MS quantification) is reported
Also listed as: Immunocapture + mass spectrometry
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| PACVS | ↕ inconsistent | healthy controls | Quantitative vaccine-encoded spike detection | Sutton et al. 2023 |
Frequently asked questions
In which conditions is Spike (LC-MS/MS quantification) altered?
In the OSMF atlas Spike (LC-MS/MS quantification) is reported in PACVS. It is mixed in 1 across 1 entries.
Is there a standard clinical test for Spike (LC-MS/MS quantification)?
The atlas entries for Spike (LC-MS/MS quantification) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Spike (LC-MS/MS quantification) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-30 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.